329 related articles for article (PubMed ID: 17275907)
1. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.
Moore JS; Kulhavy R; Tomana M; Moldoveanu Z; Suzuki H; Brown R; Hall S; Kilian M; Poulsen K; Mestecky J; Julian BA; Novak J
Mol Immunol; 2007 Apr; 44(10):2598-604. PubMed ID: 17275907
[TBL] [Abstract][Full Text] [Related]
2. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
Gomes MM; Suzuki H; Brooks MT; Tomana M; Moldoveanu Z; Mestecky J; Julian BA; Novak J; Herr AB
Biochemistry; 2010 Jul; 49(27):5671-82. PubMed ID: 20507092
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
Takahashi K; Raska M; Stuchlova Horynova M; Hall SD; Poulsen K; Kilian M; Hiki Y; Yuzawa Y; Moldoveanu Z; Julian BA; Renfrow MB; Novak J
PLoS One; 2014; 9(2):e99026. PubMed ID: 24918438
[TBL] [Abstract][Full Text] [Related]
4. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG.
Tomana M; Matousovic K; Julian BA; Radl J; Konecny K; Mestecky J
Kidney Int; 1997 Aug; 52(2):509-16. PubMed ID: 9264010
[TBL] [Abstract][Full Text] [Related]
5. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
[TBL] [Abstract][Full Text] [Related]
6. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
7. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
Xu LX; Zhao MH
Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
[TBL] [Abstract][Full Text] [Related]
8. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
Tomana M; Novak J; Julian BA; Matousovic K; Konecny K; Mestecky J
J Clin Invest; 1999 Jul; 104(1):73-81. PubMed ID: 10393701
[TBL] [Abstract][Full Text] [Related]
9. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
Moldoveanu Z; Wyatt RJ; Lee JY; Tomana M; Julian BA; Mestecky J; Huang WQ; Anreddy SR; Hall S; Hastings MC; Lau KK; Cook WJ; Novak J
Kidney Int; 2007 Jun; 71(11):1148-54. PubMed ID: 17342176
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
Gastaldi D; Paradisi L; Baiocchi C; Medana C; Lo Duca G; Sena LM; Roccatello D
J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671
[TBL] [Abstract][Full Text] [Related]
11. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.
Leung JC; Tang SC; Chan DT; Lui SL; Lai KN
J Clin Lab Anal; 2002; 16(1):11-9. PubMed ID: 11835525
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schönlein purpura.
Saulsbury FT
J Rheumatol; 1997 Nov; 24(11):2246-9. PubMed ID: 9375892
[TBL] [Abstract][Full Text] [Related]
13. N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
Stuchlova Horynova M; Vrablikova A; Stewart TJ; Takahashi K; Czernekova L; Yamada K; Suzuki H; Julian BA; Renfrow MB; Novak J; Raska M
Nephrol Dial Transplant; 2015 Feb; 30(2):234-8. PubMed ID: 25281698
[TBL] [Abstract][Full Text] [Related]
14. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
Yasutake J; Suzuki Y; Suzuki H; Hiura N; Yanagawa H; Makita Y; Kaneko E; Tomino Y
Nephrol Dial Transplant; 2015 Aug; 30(8):1315-21. PubMed ID: 26109484
[TBL] [Abstract][Full Text] [Related]
15. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
16. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
Suzuki H; Moldoveanu Z; Hall S; Brown R; Julian BA; Wyatt RJ; Tomana M; Tomino Y; Novak J; Mestecky J
Contrib Nephrol; 2007; 157():129-33. PubMed ID: 17495450
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation profile of differently charged IgA1 and their binding characteristics to cultured mesangial cells in IgA nephropathy.
Leung JC; Chan LY; Tang SC; Tam PC; Fenn J; Lai KN
Nephron Exp Nephrol; 2007; 107(3):e107-18. PubMed ID: 17957128
[TBL] [Abstract][Full Text] [Related]
18. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis.
Allen AC; Bailey EM; Barratt J; Buck KS; Feehally J
J Am Soc Nephrol; 1999 Aug; 10(8):1763-71. PubMed ID: 10446944
[TBL] [Abstract][Full Text] [Related]
19. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
Linossier MT; Palle S; Berthoux F
Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
[TBL] [Abstract][Full Text] [Related]
20. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
Novak J; Moldoveanu Z; Renfrow MB; Yanagihara T; Suzuki H; Raska M; Hall S; Brown R; Huang WQ; Goepfert A; Kilian M; Poulsen K; Tomana M; Wyatt RJ; Julian BA; Mestecky J
Contrib Nephrol; 2007; 157():134-8. PubMed ID: 17495451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
